Background: Diabetes mellitus is a serious condition with potentially devastating complications that affects all age groups worldwide. The purposes of this study are to describe the glycemic control levels and to determine the associated factors of poor glycemic control among type 2 diabetes patients followed in Najran Armed Forces Hospital. Methods: We conducted a retrospective analysis of administrative data from adult patients with diabetes type 2 followed in NAFH clinics. To be included in the pilot study, patients needed to meet the following criteria: 1) Be identified as having diabetes type 2 using algorithms employed by disease management oasis program; 2) Be at least aged 18; 3) Be male or female; 4) Have Fasting Plasma Glucose (FPG) and HbA1c measured at least twice during the last year. Both univariate and multivariate approaches of logistic regression were applied to determine factors associated with poor glycemic control. Results: Data from a total of 100 patients were analyzed. There were 22% of patients that achieved glycemic control. The risk factors associated with poor glycemic control were being female, age < 65 years old and those who had not achieved the target total cholesterol. Conclusion: The findings of this study showed that diabetic control is suboptimal. This study provides factors that predict poor glycemic control. With this information, subgroups with high risk of disease morbidity were identified. Barriers that prevent these patients from meeting their goals must be explored to improve health outcomes.
A minority of small RCCs do not reach either a 15- or 20-HU enhancement threshold and might be misinterpreted as a hyperattenuating cyst. Most RCCs below these enhancement thresholds are papillary RCC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.